Tuesday, February 07, 2017 7:08:57 AM
Neos Therapeutics, Inc. (NASDAQ:NEOS) closed down -0.75 points or -12.93% at $5.05 with 3.73 mln shares exchanging hands. Current price level places the company’s stock about -57.02% from the 52-week high and -4.72% away from the 52-week low. Sell-side analyst recommendations point to a short term price target of $19.5 on the company shares. The consensus rating is 1.8, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $11 and a high target price of $32.
http://thewellesleysnews.com/index.php/2017/02/06/healthcare-shares-momentum-brookdale-senior-living-inc-bkd-neos-therapeutics-inc-neos/
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM